<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         dtd-version="1.1"
         xml:lang="en"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Slovenian Medical Journal</journal-title>
            <trans-title-group xml:lang="sl">
               <trans-title>Zdravniški vestnik</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2702</article-id>
         <article-id pub-id-type="publisher-id">2702</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Professional article</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Metabolic and hormonal disorders</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="en">
               <subject>Professional article</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="en">ARIA 2016 Executive Summary: Integrated care pathways for predictive medicine across the life cycle</article-title>
            <alt-title alt-title-type="running-head" xml:lang="en">Integrated care pathways for predictive medicine across the life cycle (ARIA)</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Zidarn</surname>
                  <given-names>Mihaela</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff2">2</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bajrović</surname>
                  <given-names>Nissera</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Jenko</surname>
                  <given-names>Klemen</given-names>
               </name>
               <xref ref-type="aff" rid="aff2">2</xref>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kopač</surname>
                  <given-names>Peter</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Košnik</surname>
                  <given-names>Mitja</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff2">2</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Edelbaher</surname>
                  <given-names>Natalija</given-names>
               </name>
               <xref ref-type="aff" rid="aff4">4</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Jošt</surname>
                  <given-names>Maja</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kramer Vrščaj</surname>
                  <given-names>Karmen</given-names>
               </name>
               <xref ref-type="aff" rid="aff5">5</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Koren Jeverica</surname>
                  <given-names>Anja</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Kreft</surname>
                  <given-names>Samo</given-names>
               </name>
               <xref ref-type="aff" rid="aff6">6</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Lalek</surname>
                  <given-names>Nika</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="aff" rid="aff7">7</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Madjar</surname>
                  <given-names>Bojan</given-names>
               </name>
               <xref ref-type="aff" rid="aff8">8</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Poplas Susič</surname>
                  <given-names>Antonija</given-names>
               </name>
               <xref ref-type="aff" rid="aff2">2</xref>
               <xref ref-type="aff" rid="aff9">9</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Rozman Sinur</surname>
                  <given-names>Irma</given-names>
               </name>
               <xref ref-type="aff" rid="aff10">10</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Soklič Košak</surname>
                  <given-names>Tanja</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Triller</surname>
                  <given-names>Katja</given-names>
               </name>
               <xref ref-type="aff" rid="aff11">11</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Triller</surname>
                  <given-names>Nadja</given-names>
               </name>
               <xref ref-type="aff" rid="aff12">12</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Urbančič</surname>
                  <given-names>Jure</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Agache</surname>
                  <given-names>Ioana</given-names>
               </name>
               <xref ref-type="aff" rid="aff13">13</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bachert</surname>
                  <given-names>Claus</given-names>
               </name>
               <xref ref-type="aff" rid="aff14">14</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bedbrook</surname>
                  <given-names>Anna</given-names>
               </name>
               <xref ref-type="aff" rid="aff15">15</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Canonica</surname>
                  <given-names>Giorgio Walter</given-names>
               </name>
               <xref ref-type="aff" rid="aff16">16</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Casale</surname>
                  <given-names>Thomas</given-names>
               </name>
               <xref ref-type="aff" rid="aff17">17</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Cruz</surname>
                  <given-names>Alvaro A</given-names>
               </name>
               <xref ref-type="aff" rid="aff18">18</xref>
               <xref ref-type="aff" rid="aff19">19</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Fokkens</surname>
                  <given-names>Wytske J</given-names>
               </name>
               <xref ref-type="aff" rid="aff20">20</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Hellings</surname>
                  <given-names>Peter W</given-names>
               </name>
               <xref ref-type="aff" rid="aff21">21</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Samolinski</surname>
                  <given-names>Boleslaw</given-names>
               </name>
               <xref ref-type="aff" rid="aff22">22</xref>
               <xref ref-type="aff" rid="aff23">23</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Bousquet</surname>
                  <given-names>Jean</given-names>
               </name>
               <xref ref-type="aff" rid="aff15">15</xref>
            </contrib>
         </contrib-group>
         <aff id="aff1" xml:lang="en">
            <label>1</label>
            <institution>University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia</institution>
         </aff>
         <aff id="aff2" xml:lang="en">
            <label>2</label>
            <institution>Faculty of medicine, University of Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <aff id="aff3" xml:lang="en">
            <label>3</label>
            <institution>University Medical Centre Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <aff id="aff4" xml:lang="en">
            <label>4</label>
            <institution>University Medical Centre Maribor, Maribor, Slovenia</institution>
         </aff>
         <aff id="aff5" xml:lang="en">
            <label>5</label>
            <institution>Internistična ambulanta za pljučne in alergijske bolezni Celje, Celje, Slovenia</institution>
         </aff>
         <aff id="aff6" xml:lang="en">
            <label>6</label>
            <institution>Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <aff id="aff7" xml:lang="en">
            <label>7</label>
            <institution>Hospital Topolščica, Topolščica, Slovenia</institution>
         </aff>
         <aff id="aff8" xml:lang="en">
            <label>8</label>
            <institution>Pomurske lekarne Lekarna Puconci, Puconci, Slovenia</institution>
         </aff>
         <aff id="aff9" xml:lang="en">
            <label>9</label>
            <institution>Community health centre Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <aff id="aff10" xml:lang="en">
            <label>10</label>
            <institution>General hospital Novo Mesto, Novo Mesto, Slovenia</institution>
         </aff>
         <aff id="aff11" xml:lang="en">
            <label>11</label>
            <institution>Izola General hospital, Izola, Slovenia</institution>
         </aff>
         <aff id="aff12" xml:lang="en">
            <label>12</label>
            <institution>Community health centre Murska Sobota, Murska Sobota, Slovenia</institution>
         </aff>
         <aff id="aff13" xml:lang="en">
            <label>13</label>
            <institution>Faculty of Medicine, Transylvania University, Brasov, Romania</institution>
         </aff>
         <aff id="aff14" xml:lang="en">
            <label>14</label>
            <institution>Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium</institution>
         </aff>
         <aff id="aff15" xml:lang="en">
            <label>15</label>
            <institution>MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France</institution>
         </aff>
         <aff id="aff16" xml:lang="en">
            <label>16</label>
            <institution>Personalized Medicine Clinic Asthma &amp; Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan, Italy</institution>
         </aff>
         <aff id="aff17" xml:lang="en">
            <label>17</label>
            <institution>Division of Allergy/Immunology, University of South Florida, Tampa, USA</institution>
         </aff>
         <aff id="aff18" xml:lang="en">
            <label>18</label>
            <institution>ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia, GARD/WHO Executive Committee and Federal University of Bahia, Brasil</institution>
         </aff>
         <aff id="aff19" xml:lang="en">
            <label>19</label>
            <institution>GARD/WHO Executive Committee and Federal University of Bahia, Brasil</institution>
         </aff>
         <aff id="aff20" xml:lang="en">
            <label>20</label>
            <institution>Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, Netherlands</institution>
         </aff>
         <aff id="aff21" xml:lang="en">
            <label>21</label>
            <institution>Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium</institution>
         </aff>
         <aff id="aff22" xml:lang="en">
            <label>22</label>
            <institution>Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poland</institution>
         </aff>
         <aff id="aff23" xml:lang="en">
            <label>23</label>
            <institution>VIMA. INSERM U 1168, VIMA: Ageing and chronic diseases, Epidemiological and public health approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France</institution>
         </aff>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Mihaela Zidarn, e-mail: <email xlink:type="simple"/>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>6</month>
            <year>2019</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>6</month>
            <year>2019</year>
         </pub-date>
         <volume>88</volume>
         <issue>5–6</issue>
         <fpage>291</fpage>
         <lpage>301</lpage>
         <history>
            <date date-type="received">
               <day>19</day>
               <month>1</month>
               <year>2018</year>
            </date>
            <date date-type="accepted">
               <day>15</day>
               <month>4</month>
               <year>2019</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2019, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2019, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2019</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="en">
            <title>Abstract</title>
            <p>The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA - disseminated and implemented in over 70 countries globally - is now focusing on the implementation of emerging technologies for individualised and predictive medicine. MASK (MACVIA (<italic>Contre les MAladies Chroniques pour un VIeillissement Actif</italic>)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multi-disciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.</p>
         </abstract>
         <kwd-group xml:lang="en">
            <kwd>allergic rhinitis</kwd>
            <kwd>asthma</kwd>
            <kwd>integrated care pathway</kwd>
            <kwd>mobile technology</kwd>
            <kwd>airway diseases</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Introduction">
         <label>1</label>
         <title>Introduction</title>
         <p>Patients, physicians and other care providers have different options of treating allergic rhinitis (AR). Therefore, clinical practice is diverse, and patients are often not satisfied with treatment. (<italic>angl.</italic>
            <italic> </italic>Allergic Rhinitis and its Impact on Asthma (ARIA) initiative was established in 1999 at a WHO workshop (published in 2001). Its purpose was to establish guidelines for diagnosing and treating co-current allergic rhinitis and asthma (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b2">2</xref>). The ARIA initiative was updated in 2008 (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b3">3</xref>). The revision of 2010 drew up the first guidelines for chronic pulmonary obstruction disease that uses advanced methodology to assess evidence, grade recommendations, assess, develop and evaluate (Grading of Recommendation, Assessment, Development and Evaluation, GRADE) (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b5">5</xref>).</p>
         <p>The ARIA initiative, which has been disseminated and implemented in 70 countries, is now focusing on the implementation of new technologies for personalised and predictive medicine. MASK network uses mobile technology to develop care pathways that would enable multidisciplinary groups or patients to manage rhinitis and asthma (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b8">8</xref>).</p>
         <p>The goals of the new approach within the ARIA initiative is to ensure an active and healthy life to patients with rhinitis, whatever their age, gender and socio-economic status in order to reduce health and social inequalities incurred by the disease.</p>
         <p>The article was published in December 2016 in Clinical and Translational Allergy journal.</p>
         <p>By translating the article into Slovene, we would like present novel management of patients with a chronic disease by using modern technology that enables cooperation of all stakeholders, i.e. from pharmacists in pharmacies to general physicians and specialists.</p>
      </sec>
      <sec id="s2"
           sec-type="Integrated care pathways for airway diseases, AIRWAYS ICPs): priority tasks of ARIA 2016">
         <label>2</label>
         <title>Integrated care pathways for airway diseases, AIRWAYS ICPs): priority tasks of ARIA 2016</title>
         <p>In 2012, the European Commission launched the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). The aim was to enhance EU competitiveness and tackle societal challenges through research and innovation (<xref ref-type="bibr" rid="b9">9</xref>). The B3 Action Plan is devoted to the scaling up and replication of successful innovative integrated care models for chronic diseases among adult patients. Chronic respiratory diseases were selected to be the pilot project.</p>
         <p>AIRWAYS ICPs is the implementation tool of the EPI on AHA project. AIRWAYS ICPs aims to develop practical multi-sectoral care pathways (i.e. ICPs) – of rhinitis, asthma and associated diseases by implementing new predictive medicine technology across the life cycle of patients (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b10">10</xref>). The aims are to reduce chronic respiratory disease burden, mortality and multi-morbidity, while maintaining patients’ quality-of-life (<xref ref-type="bibr" rid="b7">7</xref>,<xref ref-type="bibr" rid="b11">11</xref>). AIRWAYS ICPs has been implemented and disseminated globally (<xref ref-type="bibr" rid="b12">12</xref>), while becoming a sample project of the World Health Organisation Global Alliance against Chronic Respiratory Diseases (WHO GARD) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). ARIA 2016 is a major part of AIRWAYS ICPs (<xref ref-type="bibr" rid="b13">13</xref>).</p>
         <fig position="anchor" id="fig1">
            <label>Figure 1:</label>
            <caption>
               <p> Links between AIRWAYS ICPs, the European Union and WHO (adapted from Bousquet et al) (<xref ref-type="bibr" rid="b11">11</xref>).</p>
            </caption>
            <p>
               <graphic xlink:href="2702-en-web-resources/image/zdravvestn-2702-en-01.png"/>
            </p>
            <p>NGO: nongovernmental organisation; GO: Governmental organisation; MOH: Ministry of Health; WHO GARD World Health Organisation Global Alliance against Chronic Respiratory Diseases; NCD: Non-communicable disease; DG: Directorate General; DG Sante: Directorate-General for Health and Food Safety; DG CONNECT: The Directorate General for Communications Networks, Content and Technology; DG Research: Directorate General for Research and Innovation; AIRWAYS ICPs: Integrated care pathways for airway disease; EIP on AHA: European Innovation Partnership on Active and Healthy Ageing.</p>
         </fig>
      </sec>
      <sec id="s3"
           sec-type="From guidelines to integrated clinical pathways: MASK network">
         <label>3</label>
         <title>From guidelines to integrated clinical pathways: MASK network</title>
         <sec id="s3.1"
              sec-type="The need for multi-sectoral clinical pathways for rhinitis and asthma by using ICP">
            <label>3.1</label>
            <title>The need for multi-sectoral clinical pathways for rhinitis and asthma by using ICP</title>
            <p>Patients with AR are often self-managed. They rarely consult physicians on using AR drugs (<xref ref-type="bibr" rid="b14">14</xref>), although AR negatively impacts many activities – their social life, school and work productivity (<xref ref-type="bibr" rid="b3">3</xref>). Many patients with AR use over the counter drugs that are available without a prescription (<xref ref-type="bibr" rid="b15">15</xref>-<xref ref-type="bibr" rid="b17">17</xref>), only few of them consult their physician. Most patients who visit their personal physician or a specialist have moderate to severe rhinitis (<xref ref-type="bibr" rid="b18">18</xref>-<xref ref-type="bibr" rid="b20">20</xref>). Patients have several types of medication available (on prescription or OTC), can undergo specific immunotherapy or choose alternative medicine (<xref ref-type="bibr" rid="b21">21</xref>). According to AIRWAYS ICP recommendations, integrated clinical pathways should consider a multi-disciplinary approach, including self-management (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
            <fig position="anchor" id="fig2">
               <label>Figure 2:</label>
               <caption>
                  <p> Multi-sectoral pathway for allergic phinitis (adapted from Bosquet et al) (<xref ref-type="bibr" rid="b25">25</xref>).</p>
               </caption>
               <p>
                  <graphic xlink:href="2702-en-web-resources/image/zdravvestn-2702-en-02.png"/>
               </p>
            </fig>
            <p>ICPs are structured multidisciplinary plans of care that define key steps in patient care. They promote the translation of guidelines into local protocols their application to clinical practice. ICPs differ from clinical guidelines, as they are applied by multidisciplinary teams, focusing on the quality and coordination of care. ICPs need to have a mechanism for recording variations/deviations from planned care</p>
            <p>Variations of or deviations from recommended treatment have been carefully studied in accordance with ARIA guidelines. The severity of the disease is related to different factors of treatment and also with the quality of life (<xref ref-type="bibr" rid="b18">18</xref>-<xref ref-type="bibr" rid="b20">20</xref>). According to some studies (<xref ref-type="bibr" rid="b22">22</xref>) classification of rhinitis (intermittent, persistent: mild or moderate, severe) is a significant indicator of associated asthma, and the same applies to the duration and efficacy in AR treatment (<xref ref-type="bibr" rid="b23">23</xref>). Most patients with AR receive combinations of oral antihistamines and intra-nasal corticosteroids, which, however, are not evaluated in guidelines using an appropriate methodology (<xref ref-type="bibr" rid="b24">24</xref>).</p>
         </sec>
         <sec id="s3.2"
              sec-type="Simple approach to assessing control in allergic rhinitis">
            <label>3.2</label>
            <title>Simple approach to assessing control in allergic rhinitis</title>
            <p>According to ARIA guidelines, disease control rather than symptom severity is used to guide treatment decisions. The tools include:</p>
            <list>
               <list-item>
                  <label>1.</label>
                  <p>visual analogue scale (VAS) as the common validated language of AR control,</p>
               </list-item>
               <list-item>
                  <label>2.</label>
                  <p>categorisation of AR control using VAS score cut-offs,</p>
               </list-item>
               <list-item>
                  <label>3.</label>
                  <p>incorporation of visual analogue scale into simple interactive apps for both patients (ARIA Allergy Diary) and health care providers (ARIA Allergy Diary Companion) (<xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>),</p>
               </list-item>
               <list-item>
                  <label>4.</label>
                  <p>integration of this knowledge into ICPs (<xref ref-type="bibr" rid="b25">25</xref>) and</p>
               </list-item>
               <list-item>
                  <label>5.</label>
                  <p>the development of systems that assist in clinical decisions (clinical decision support system, CDSS).</p>
               </list-item>
            </list>
            <p>AR systems change daily and require increasing or decreasing individual therapeutic doses. Patients, caretakers or healthcare providers should employ a joint and simple system to score AR symptoms that can respond quickly to change. MACVIA-ARIA has produced a simple VAS-based ARIA CDSS algorithm using a VAS score to guide treatment decisions in a step-up/step-down approach (<xref ref-type="bibr" rid="b27">27</xref>). Using ARIA Allergy Diary Companion, a general physician or specialist can access data from the patient’s ARIA Allergy Diary and adjust therapeutic consultation with the help of ARIA CDSS algorithm.</p>
            <table-wrap position="anchor" id="table1">
               <label>Table 1:</label>
               <caption>
                  <p> Baseline questionnaire.</p>
               </caption>
               <table>
                  <colgroup>
                     <col/>
                  </colgroup>
                  <tbody>
                     <tr>
                        <th content-type="table-subhead">Q1: I have rhinitis: YES/NO</th>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q2: I have asthma: YES/NO</th>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q3: My symptoms (select):</th>
                     </tr>
                     <tr>
                        <td>
                           <p>•runny nose</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•itchy nose</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Sneezing</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•congestion (blocked nose)</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•red eyes</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•itchy eyes</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•watery eyes</p>
                        </td>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q4: How do the symptoms affect me? (select):</th>
                     </tr>
                     <tr>
                        <td>
                           <p>•affect my sleep</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•restrict my daily activities</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•restrict my participation in school or work</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•are troublesome</p>
                        </td>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q5: Medications</th>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q6: Are you currently receiving immunotherapy (a small dose of the thing you are allergic to, taken as an injection or placed under your tongue)?? YES/NO</th>
                     </tr>
                     <tr>
                        <td>If you responded YES to Q6, please answer questions Q7 and Q8.</td>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q7: What allergy is this?</th>
                     </tr>
                     <tr>
                        <td>
                           <p>•Grass pollen</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Parietaria pollen</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Birch pollen</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Other pollen</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Dust mites</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Animal</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Cypress tree pollen</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•I don’t know</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Add allergen</p>
                        </td>
                     </tr>
                     <tr>
                        <th content-type="table-subhead">Q8: How do you receive treatment?</th>
                     </tr>
                     <tr>
                        <td>
                           <p>•Injection</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Tablet under the tongue</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Drops under the tongue</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Spray under the tongue</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>•Other</p>
                        </td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
         </sec>
         <sec id="s3.3"
              sec-type="The MASK tools: the ARIA Allergy Diary and ARIA Allergy Diary Companion apps">
            <label>3.3</label>
            <title>The MASK tools: the ARIA Allergy Diary and ARIA Allergy Diary Companion apps</title>
            <p>The ARIA Allergy Diary and ARIA Allergy Diary Companion (<xref ref-type="bibr" rid="b26">26</xref>) are freely available to patients and health care providers in 15 EU member states, Australia, Brazil, Canada, Mexico and Switzerland. While they are available in 15 languages (translated from English into target languages, culturally adapted and legally compliant), they have not been translated into Slovene yet.</p>
            <sec id="s3.3.1" sec-type="Questionnaires">
               <label>3.3.1</label>
               <title>Questionnaires</title>
               <p>ARIA Allergy Diary users fill in simple questionnaires on asthma, rhinitis and the impact of the disease (globally, on work and school, on daily activities and on sleep) upon registration (<xref ref-type="table" rid="table1">Table 1</xref>). The pilot study of around 5000 users (9% over 60 years of age) indicates that these questions are easily answered and can help to stratify patients with rhinitis (<xref ref-type="bibr" rid="b28">28</xref>). Moreover, two specific questionnaires are applied every week to assess disease impact on patients’ quality of life (<xref ref-type="bibr" rid="b29">29</xref>) and productivity at work (<xref ref-type="bibr" rid="b30">30</xref>).</p>
            </sec>
            <sec id="s3.3.2" sec-type="Treatment">
               <label>3.3.2</label>
               <title>Treatment</title>
               <p>ARIA Allergy Diary includes a list of all treatments available for asthma, conjunctivitis and rhinitis. Users select the treatment they are taking: multiple treatments may be selected, and users can update the information if their treatment changes (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The list has been customised for all 20 countries in which the ARIA Allergy Diary is available. On the day of first use, the patient also enters information on any allergen specific immunotherapy.</p>
               <fig position="anchor" id="fig3">
                  <label>Figure 3:</label>
                  <caption>
                     <p> A screen on medications</p>
                  </caption>
                  <p>
                     <graphic xlink:href="2702-en-web-resources/image/zdravvestn-2702-sl-03.jpg"/>
                  </p>
               </fig>
            </sec>
            <sec id="s3.3.3" sec-type="Daily visual analogue scales">
               <label>3.3.3</label>
               <title>Daily visual analogue scales</title>
               <p>Geolocalised users assess their daily symptom control using the touchscreen functionality on their smart phone to click on 5 consecutive visual analogue scales (global symptoms due to allergic diseases, rhinitis, conjunctivitis, asthma and work productivity) (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p>
               <fig position="anchor" id="fig4">
                  <label>Figure 4:</label>
                  <caption>
                     <p> A screen on visual analogue scales.</p>
                  </caption>
                  <p>
                     <graphic xlink:href="2702-en-web-resources/image/zdravvestn-2702-sl-04.jpg"/>
                  </p>
               </fig>
            </sec>
            <sec id="s3.3.4" sec-type="Clinical decision support system">
               <label>3.3.4</label>
               <title>Clinical decision support system</title>
               <p>The MASK CDSS is incorporated into an app for health care providers. It is an algorithm that aids clinicians to select pharmacotherapy for patients with AR and to stratify their disease severity (<xref ref-type="bibr" rid="b27">27</xref>). It uses a simple step-up/step-down individualized approach to AR pharmacotherapy.</p>
            </sec>
         </sec>
      </sec>
      <sec id="s4"
           sec-type="New concepts in allergic multimorbidity included in the ARIA">
         <label>4</label>
         <title>New concepts in allergic multimorbidity included in the ARIA</title>
         <sec id="s4.1"
              sec-type="Stratification of patients with severe allergies and/or asthma">
            <label>4.1</label>
            <title>Stratification of patients with severe allergies and/or asthma</title>
            <p>Despite the major advances in understanding allergic diseases or asthma, treatments are not effective in all patients (<xref ref-type="bibr" rid="b31">31</xref>). MASK tool should be used to provide more effective therapeutic interventions tailored to the individual.</p>
            <p>Long-term birth cohort studies are essential for understanding the life course of allergic diseases (including asthma and rhinitis) and the complex interplay between genes and environment (<xref ref-type="bibr" rid="b32">32</xref>). Birth cohorts are longterm studies of children born in a geographical area who are then followed growing up. Some cohorts have followed up through adulthood. In the last 30 years, there have been over 100 studies of birth cohorts focusing on asthma and allergies. Merging data from several birth cohort studies also enables greater statistical capability in defining the factors influencing the course of allergies (<xref ref-type="bibr" rid="b32">32</xref>). The BAMSE (Barn Allergi Milj Stockholm Epidemiologi Projektet) (<xref ref-type="bibr" rid="b33">33</xref>) and MeDALL (Mechanisms of Development of ALLergy, European Union Framework Programme 7, project no. 261357; 2010–2015) (<xref ref-type="bibr" rid="b34">34</xref>) projects defined a rare phenotype which shows a proclivity towards more severe forms of allergy disease: multimorbid polysensitized phenotype, which has been confirmed in cohorts of patients with children and adults (<xref ref-type="bibr" rid="b35">35</xref>-<xref ref-type="bibr" rid="b38">38</xref>). These studies and both projects show that subjects who are polysensitised and multimorbid have a very high frequency of allergic symptoms, persistent symptoms over time, more severe asthma symptoms and higher total and specific IgE level than other phenotypes.</p>
            <p>The results confirm that asthmatic patients cannot be managed appropriately without considering associated rhinitis. The results reinforce the importance of nasal problems (rhinitis and/or rhinosinusitis) in many uncontrolled asthmatic patients (<xref ref-type="bibr" rid="b39">39</xref>,<xref ref-type="bibr" rid="b40">40</xref>).</p>
         </sec>
         <sec id="s4.2" sec-type="Allergic multimorbidity in the elderly">
            <label>4.2</label>
            <title>Allergic multimorbidity in the elderly</title>
            <p>Insufficient attention has been put on the expected epidemic wave of asthma and rhinitis in older adults, who have specific symptoms and treatment needs. These patients also suffer from multi-morbidity and receive multiple medications. Integrated clinical pathways for rhinitis and asthma should cover the entire life cycle.</p>
         </sec>
      </sec>
      <sec id="s5"
           sec-type="Growth strategy and scaling upAIRWAYs ICP in Slovenia">
         <label>5</label>
         <title>Growth strategy and scaling upAIRWAYs ICP in Slovenia</title>
         <p>Growth strategies and scaling-up are of vital improtance, as they enable: 1. avoiding fragmentation, 2. improving health care delivery across Europe, 3. speeding up the implementation of good practices using existing cost-effective success stories and 4. meeting the EIP on AHA objectives (<xref ref-type="bibr" rid="b9">9</xref>). AIRWAYs ICP growth and scaling-up strategy has already been applied to the chronic respiratory diseases action plan of the EIP on AHA (<xref ref-type="bibr" rid="b12">12</xref>).</p>
         <p>In Slovenia, we are planning to translation the ARIA Allergy Diary for patients and the ARIA Allergy Diary Companion for health care providers as they are not available yet. Moreover, we would like to localise the ARIA guidelines and combine them with the guidelines for rating non-allergic rhinitis. We have formed a working group that includes primary care physicians, allergology and pulmology specialists, ENT specialists, paediatricians and phamacists who are consulted in self-managed rhinitis, considering tried treatment methods.</p>
      </sec>
      <sec id="s6" sec-type="Conclusion">
         <label>6</label>
         <title>Conclusion</title>
         <p>The ARIA initiative has developed from clearly defined guidelines to a so-called implementation strategy based on mobile technology. It aims to ensure an active and healthy life to patients with rhinitis whatever their age, gender and socio-economic status in order to reduce health and social inequalities incurred by the disease.</p>
      </sec>
      <sec id="s7" sec-type="Funding">
         <label>7</label>
         <title>Funding</title>
         <p>The article was made within the project financed by the European Innovation Partnership in Active and Healthy Ageing.</p>
      </sec>
      <sec id="s8" sec-type="Reference page">
         <label>8</label>
         <title>Reference page</title>
         <p>MACVIA, France, EU-Structural and Development Fund Languedoc-Roussillon, ARIA</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <ref id="b1">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Shekelle</surname>
                     <given-names>PG</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Woolf</surname>
                     <given-names>SH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eccles</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grimshaw</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Clinical guidelines: developing guidelines</article-title>. 
                    <source>BMJ</source>. 
                    <year>1999</year>
                    <month>Feb</month>;
                    <volume>318</volume>(
                    <issue>7183</issue>):
                    <fpage>593</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/bmj.318.7183.593</pub-id>
                    <pub-id pub-id-type="pmid">10037645</pub-id>
                    <issn>0959-8138</issn>
                </mixed-citation>
         </ref>
         <ref id="b2">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Van Cauwenberge</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khaltaev</surname>
                     <given-names>N</given-names>
                  </name>; 
                        <collab>Aria Workshop Group</collab>; 
                        <collab>World Health Organization</collab>
                    </person-group>. 
                    <article-title>Allergic rhinitis and its impact on asthma</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2001</year>
                    <month>Nov</month>;
                    <volume>108</volume>(
                    <issue>5</issue>
                    <supplement>Suppl</supplement>):
                    <fpage>S147</fpage>–
                    <lpage>334</lpage>. 
                    <pub-id pub-id-type="doi">10.1067/mai.2001.118891</pub-id>
                    <pub-id pub-id-type="pmid">11707753</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b3">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khaltaev</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cruz</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Denburg</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fokkens</surname>
                     <given-names>WJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Togias</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>AllerGen</collab>
                    </person-group>. 
                    <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)</article-title>. 
                    <source>Allergy</source>. 
                    <year>2008</year>
                    <month>Apr</month>;
                    <volume>63</volume>
                    <supplement>Suppl 86</supplement>:
                    <fpage>8</fpage>–
                    <lpage>160</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2007.01620.x</pub-id>
                    <pub-id pub-id-type="pmid">18331513</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b4">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Brozek</surname>
                     <given-names>JL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baena-Cagnani</surname>
                     <given-names>CE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bonini</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Casale</surname>
                     <given-names>TB</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>Global Allergy and Asthma European Network</collab>; 
                        <collab>Grading of Recommendations Assessment, Development and Evaluation Working Group</collab>
                    </person-group>. 
                    <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2010</year>
                    <month>Sep</month>;
                    <volume>126</volume>(
                    <issue>3</issue>):
                    <fpage>466</fpage>–
                    <lpage>76</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2010.06.047</pub-id>
                    <pub-id pub-id-type="pmid">20816182</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b5">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Padjas</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kehar</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Aleem</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mejza</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schunemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>. 
                    <article-title>Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2014</year>;
                    <month>Apr</month>;
                    <volume>133</volume>
                    <issue>3</issue>:
                    <fpage>777</fpage>–
                    <lpage>84.e4</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2013.08.029</pub-id>
                    <pub-id pub-id-type="pmid">24139606</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b6">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schünemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Samolinski</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baena-Cagnani</surname>
                     <given-names>CE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>World Health Organization Collaborating Center for Asthma and Rhinitis</collab>
                    </person-group>. 
                    <article-title>Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2012</year>
                    <month>Nov</month>;
                    <volume>130</volume>(
                    <issue>5</issue>):
                    <fpage>1049</fpage>–
                    <lpage>62</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2012.07.053</pub-id>
                    <pub-id pub-id-type="pmid">23040884</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b7">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Addis</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Adcock</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Agache</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Agusti</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Alonso</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>European Innovation Partnership on Active and Healthy Ageing, Action Plan B3</collab>; 
                        <collab>Mechanisms of the Development of Allergy, WP 10</collab>; 
                        <collab>Global Alliance against Chronic Respiratory Diseases</collab>
                    </person-group>. 
                    <article-title>Integrated care pathways for airway diseases (AIRWAYS-ICPs)</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2014</year>
                    <month>Aug</month>;
                    <volume>44</volume>(
                    <issue>2</issue>):
                    <fpage>304</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1183/09031936.00014614</pub-id>
                    <pub-id pub-id-type="pmid">24925919</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
         </ref>
         <ref id="b8">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>PW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Agache</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bergmann</surname>
                     <given-names>KC</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle</article-title>. 
                    <source>Clin Transl Allergy</source>. 
                    <year>2016</year>
                    <month>Dec</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>47</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13601-016-0137-4</pub-id>
                    <pub-id pub-id-type="pmid">28050247</pub-id>
                    <issn>2045-7022</issn>
                </mixed-citation>
         </ref>
         <ref id="b9">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Michel</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Standberg</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Crooks</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Iakovidis</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gomez</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column</article-title>. 
                    <source>Eur Geriatr Med</source>. 
                    <year>2014</year>;
                    <volume>5</volume>(
                    <issue>6</issue>):
                    <fpage>361</fpage>–
                    <lpage>2</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.eurger.2014.09.010</pub-id>
                    <issn>1878-7649</issn>
                </mixed-citation>
         </ref>
         <ref id="b10">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anto</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Berkouk</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gergen</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Antunes</surname>
                     <given-names>JP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Augé</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Developmental determinants in non-communicable chronic diseases and ageing</article-title>. 
                    <source>Thorax</source>. 
                    <year>2015</year>
                    <month>Jun</month>;
                    <volume>70</volume>(
                    <issue>6</issue>):
                    <fpage>595</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/thoraxjnl-2014-206304</pub-id>
                    <pub-id pub-id-type="pmid">25616486</pub-id>
                    <issn>0040-6376</issn>
                </mixed-citation>
         </ref>
         <ref id="b11">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Barbara</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bateman</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bel</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chavannes</surname>
                     <given-names>NH</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>AIRWAYS-ICPs working group</collab>
                    </person-group>. 
                    <article-title>AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation</article-title>. 
                    <source>Eur Respir J</source>. 
                    <year>2016</year>
                    <month>Apr</month>;
                    <volume>47</volume>(
                    <issue>4</issue>):
                    <fpage>1028</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1183/13993003.01856-2015</pub-id>
                    <pub-id pub-id-type="pmid">27037308</pub-id>
                    <issn>0903-1936</issn>
                </mixed-citation>
         </ref>
         <ref id="b12">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Farrell</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Crooks</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bel</surname>
                     <given-names>EH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)</article-title>. 
                    <source>Clin Transl Allergy</source>. 
                    <year>2016</year>
                    <month>Jul</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>29</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13601-016-0116-9</pub-id>
                    <pub-id pub-id-type="pmid">27478588</pub-id>
                    <issn>2045-7022</issn>
                </mixed-citation>
         </ref>
         <ref id="b13">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cano</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eklund</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fico</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goswami</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA</article-title>. 
                    <source>J Nutr Health Aging</source>. 
                    <year>2017</year>;
                    <volume>21</volume>(
                    <issue>1</issue>):
                    <fpage>92</fpage>–
                    <lpage>104</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s12603-016-0803-1</pub-id>
                    <pub-id pub-id-type="pmid">27999855</pub-id>
                    <issn>1279-7707</issn>
                </mixed-citation>
         </ref>
         <ref id="b14">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Kuehl</surname>
                     <given-names>BL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Abdulnour</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>O’Dell</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kyle</surname>
                     <given-names>TK</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Understanding the role of the healthcare professional in patient self-management of allergic rhinitis</article-title>. 
                    <source>SAGE Open Med</source>. 
                    <year>2015</year>
                    <month>Aug</month>;
                    <volume>3</volume>:
                    <fpage>2050312115595822</fpage>. 
                    <pub-id pub-id-type="doi">10.1177/2050312115595822</pub-id>
                    <pub-id pub-id-type="pmid">26770793</pub-id>
                    <issn>2050-3121</issn>
                </mixed-citation>
         </ref>
         <ref id="b15">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>van Cauwenberge</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khaltaev</surname>
                     <given-names>N</given-names>
                  </name>; 
                        <collab>Members of the Workshops</collab>
                    </person-group>. 
                    <article-title>ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma</article-title>. 
                    <source>Allergy</source>. 
                    <year>2004</year>
                    <month>Apr</month>;
                    <volume>59</volume>(
                    <issue>4</issue>):
                    <fpage>373</fpage>–
                    <lpage>87</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2003.00468.x</pub-id>
                    <pub-id pub-id-type="pmid">15005760</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b16">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Triggiani</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Senna</surname>
                     <given-names>G</given-names>
                  </name>
                    </person-group>. 
                    <article-title>360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients</article-title>. 
                    <source>Clin Mol Allergy</source>. 
                    <year>2015</year>
                    <month>Nov</month>;
                    <volume>13</volume>(
                    <issue>1</issue>):
                    <fpage>25</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s12948-015-0029-5</pub-id>
                    <pub-id pub-id-type="pmid">26528081</pub-id>
                    <issn>1476-7961</issn>
                </mixed-citation>
         </ref>
         <ref id="b17">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Meltzer</surname>
                     <given-names>EO</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Farrar</surname>
                     <given-names>JR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sennett</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients</article-title>. 
                    <source>J Allergy Clin Immunol Pract</source>. 
                    <year>2017</year>                    
                    <month>May</month>;
                    <volume>5</volume>(
                    <issue>3</issue>):
                    <fpage>779</fpage>-
                    <lpage>89.e6</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.10.010</pub-id>
                    <pub-id pub-id-type="pmid">27914815</pub-id>
                    <issn>2213-2198</issn>
                </mixed-citation>
         </ref>
         <ref id="b18">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Annesi-Maesano</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Carat</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Léger</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rugina</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pribil</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group</article-title>. 
                    <source>Clin Exp Allergy</source>. 
                    <year>2005</year>
                    <month>Jun</month>;
                    <volume>35</volume>(
                    <issue>6</issue>):
                    <fpage>728</fpage>–
                    <lpage>32</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1365-2222.2005.02274.x</pub-id>
                    <pub-id pub-id-type="pmid">15969662</pub-id>
                    <issn>0954-7894</issn>
                </mixed-citation>
         </ref>
         <ref id="b19">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Devillier</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tadmouri</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mesbah</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study</article-title>. 
                    <source>Int Arch Allergy Immunol</source>. 
                    <year>2015</year>;
                    <volume>166</volume>(
                    <issue>3</issue>):
                    <fpage>231</fpage>–
                    <lpage>40</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000381339</pub-id>
                    <pub-id pub-id-type="pmid">25924687</pub-id>
                    <issn>1018-2438</issn>
                </mixed-citation>
         </ref>
         <ref id="b20">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>del Cuvillo</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Montoro</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bartra</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Valero</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferrer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jauregui</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study</article-title>. 
                    <source>Rhinology</source>. 
                    <year>2010</year>
                    <month>Jun</month>;
                    <volume>48</volume>(
                    <issue>2</issue>):
                    <fpage>201</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.4193/Rhin09.099</pub-id>
                    <pub-id pub-id-type="pmid">20502761</pub-id>
                    <issn>0300-0729</issn>
                </mixed-citation>
         </ref>
         <ref id="b21">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Calderon</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Casale</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Akdis</surname>
                     <given-names>CA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project</article-title>. 
                    <source>Clin Transl Allergy</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>41</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13601-016-0131-x</pub-id>
                    <pub-id pub-id-type="pmid">27895895</pub-id>
                    <issn>2045-7022</issn>
                </mixed-citation>
         </ref>
         <ref id="b22">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Cruz</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Popov</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pawankar</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Annesi-Maesano</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fokkens</surname>
                     <given-names>W</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kemp</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>ARIA Initiative Scientific Committee</collab>
                    </person-group>. 
                    <article-title>Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN</article-title>. 
                    <source>Allergy</source>. 
                    <year>2007</year>;
                    <volume>62</volume>(
                    <issue>s84</issue>
                    <supplement>Suppl 84</supplement>):
                    <fpage>1</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1398-9995.2007.01551.x</pub-id>
                    <pub-id pub-id-type="pmid">17924930</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b23">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Devillier</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tadmouri</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mesbah</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life study</article-title>. 
                    <source>Int Arch Allergy Immunol</source>. 
                    <year>2015</year>;
                    <volume>166</volume>(
                    <issue>3</issue>):
                    <fpage>231</fpage>–
                    <lpage>40</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000381339</pub-id>
                    <pub-id pub-id-type="pmid">25924687</pub-id>
                    <issn>1018-2438</issn>
                </mixed-citation>
         </ref>
         <ref id="b24">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Meltzer</surname>
                     <given-names>EO</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wallace</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dykewicz</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Shneyer</surname>
                     <given-names>L</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?</article-title> 
                    <source>J Allergy Clin Immunol Pract</source>. 
                    <year>2016</year>;
                    <month>Jul-Aug</month>;
                    <volume>4</volume>(
                    <issue>4</issue>):
                    <fpage>682</fpage>–
                    <lpage>8.e6</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.02.006</pub-id>
                    <pub-id pub-id-type="pmid">27084419</pub-id>
                </mixed-citation>
         </ref>
         <ref id="b25">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schunemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fonseca</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Samolinski</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation</article-title>. 
                    <source>Allergy</source>. 
                    <year>2015</year>
                    <month>Nov</month>;
                    <volume>70</volume>(
                    <issue>11</issue>):
                    <fpage>1372</fpage>–
                    <lpage>92</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/all.12686</pub-id>
                    <pub-id pub-id-type="pmid">26148220</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b26">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bourret</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mercier</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Camuzat</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Demoly</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis</article-title>. 
                    <source>World Hosp Health Serv</source>. 
                    <year>2015</year>;
                    <volume>51</volume>(
                    <issue>3</issue>):
                    <fpage>36</fpage>–
                    <lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">26571642</pub-id>
                    <issn>1029-0540</issn>
                </mixed-citation>
         </ref>
         <ref id="b27">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schunemann</surname>
                     <given-names>HJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>PW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Arnavielhe</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2016</year> 
                    <month>May-Jun</month>;
                    <volume>138</volume>(
                    <issue>2</issue>):
                    <fpage>367</fpage>–
                    <lpage>74.e2</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.10.010</pub-id>
                    <pub-id pub-id-type="pmid">27914815</pub-id>
                    <issn>2213-2198</issn>
                </mixed-citation>
         </ref>
         <ref id="b28">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Caimmi</surname>
                     <given-names>DP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bedbrook</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bewick</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hellings</surname>
                     <given-names>PW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Devillier</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study</article-title>. 
                    <source>Allergy</source>. 
                    <year>2017</year>
                    <month>Jun</month>;
                    <volume>72</volume>(
                    <issue>6</issue>):
                    <fpage>857</fpage>–
                    <lpage>65</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/all.13125</pub-id>
                    <pub-id pub-id-type="pmid">28072463</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b29">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>König</surname>
                     <given-names>HH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bernert</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Angermeyer</surname>
                     <given-names>MC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Matschinger</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Martinez</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vilagut</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>ESEMeD/MHEDEA 2000 Investigators</collab>
                    </person-group>. 
                    <article-title>Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire</article-title>. 
                    <source>Med Care</source>. 
                    <year>2009</year>
                    <month>Feb</month>;
                    <volume>47</volume>(
                    <issue>2</issue>):
                    <fpage>255</fpage>–
                    <lpage>61</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/MLR.0b013e318184759e</pub-id>
                    <pub-id pub-id-type="pmid">19169128</pub-id>
                    <issn>0025-7079</issn>
                </mixed-citation>
         </ref>
         <ref id="b30">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Blanc</surname>
                     <given-names>PD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Trupin</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eisner</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Earnest</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Katz</surname>
                     <given-names>PP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Israel</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The work impact of asthma and rhinitis: findings from a population-based survey</article-title>. 
                    <source>J Clin Epidemiol</source>. 
                    <year>2001</year>
                    <month>Jun</month>;
                    <volume>54</volume>(
                    <issue>6</issue>):
                    <fpage>610</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0895-4356(00)00349-8</pub-id>
                    <pub-id pub-id-type="pmid">11377122</pub-id>
                    <issn>0895-4356</issn>
                </mixed-citation>
         </ref>
         <ref id="b31">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bachert</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Canonica</surname>
                     <given-names>GW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Casale</surname>
                     <given-names>TB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cruz</surname>
                     <given-names>AA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lockey</surname>
                     <given-names>RJ</given-names>
                  </name>, 
                        <etal>et al</etal>; 
                        <collab>Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asthma Study Group</collab>
                    </person-group>. 
                    <article-title>Unmet needs in severe chronic upper airway disease (SCUAD)</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2009</year>
                    <month>Sep</month>;
                    <volume>124</volume>(
                    <issue>3</issue>):
                    <fpage>428</fpage>–
                    <lpage>33</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2009.06.027</pub-id>
                    <pub-id pub-id-type="pmid">19660803</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b32">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anto</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sunyer</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Nieuwenhuijsen</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vrijheid</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Keil</surname>
                     <given-names>T</given-names>
                  </name>; 
                        <collab>MeDALL Study Group</collab>; 
                        <collab>CHICOS Study Group</collab>; 
                        <collab>ENRIECO Study Group</collab>; 
                        <collab>GA²LEN Study Group</collab>
                    </person-group>. 
                    <article-title>Pooling birth cohorts in allergy and asthma: european Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper</article-title>. 
                    <source>Int Arch Allergy Immunol</source>. 
                    <year>2013</year>;
                    <volume>161</volume>(
                    <issue>1</issue>):
                    <fpage>1</fpage>–
                    <lpage>10</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000343018</pub-id>
                    <pub-id pub-id-type="pmid">23258290</pub-id>
                    <issn>1018-2438</issn>
                </mixed-citation>
         </ref>
         <ref id="b33">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Westman</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lupinek</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Andersson</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pahr</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baar</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2015</year>
                    <month>May</month>;
                    <volume>135</volume>(
                    <issue>5</issue>):
                    <fpage>1199</fpage>–
                    <lpage>106.e1-11</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2014.10.042</pub-id>
                    <pub-id pub-id-type="pmid">25528361</pub-id>
                    <issn>0091-6749</issn>                    
                </mixed-citation>
         </ref>
         <ref id="b34">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anto</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Akdis</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Auffray</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Keil</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Momas</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015</article-title>. 
                    <source>Allergy</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>71</volume>(
                    <issue>11</issue>):
                    <fpage>1513</fpage>–
                    <lpage>25</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/all.12880</pub-id>
                    <pub-id pub-id-type="pmid">26970340</pub-id>
                    <issn>0105-4538</issn>
                </mixed-citation>
         </ref>
         <ref id="b35">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Burte</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Varraso</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gormand</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Just</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Matran</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study</article-title>. 
                    <source>PLoS One</source>. 
                    <year>2015</year>
                    <month>Aug</month>;
                    <volume>10</volume>(
                    <issue>8</issue>):
                    <fpage>e0136191</fpage>. 
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0136191</pub-id>
                    <pub-id pub-id-type="pmid">26309034</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
         </ref>
         <ref id="b36">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Siroux</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lupinek</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Resch</surname>
                     <given-names>Y</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Curin</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Just</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Keil</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: the EGEA study</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2017</year> 
                    <month>Feb</month>;
                    <volume>139</volume>(
                    <issue>2</issue>):
                    <fpage>643</fpage>. 
                    <lpage>654.e6</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2016.05.023</pub-id>
                    <pub-id pub-id-type="pmid">27464960</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b37">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Just</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Elegbede</surname>
                     <given-names>CF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Deschildre</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bousquet</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Moneret-Vautrin</surname>
                     <given-names>DA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Crepet</surname>
                     <given-names>A</given-names>
                  </name>; 
                        <collab>Mirabel study group</collab>
                    </person-group>. 
                    <article-title>Three peanut-allergic/sensitized phenotypes with gender difference</article-title>. 
                    <source>Clin Exp Allergy</source>. 
                    <year>2016</year>
                    <month>Dec</month>;
                    <volume>46</volume>(
                    <issue>12</issue>):
                    <fpage>1596</fpage>–
                    <lpage>604</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/cea.12791</pub-id>
                    <pub-id pub-id-type="pmid">27512923</pub-id>
                    <issn>0954-7894</issn>
                </mixed-citation>
         </ref>
         <ref id="b38">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Zoratti</surname>
                     <given-names>EM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Krouse</surname>
                     <given-names>RZ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Babineau</surname>
                     <given-names>DC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pongracic</surname>
                     <given-names>JA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>O’Connor</surname>
                     <given-names>GT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wood</surname>
                     <given-names>RA</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Asthma phenotypes in inner-city children</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2016</year>
                    <month>Oct</month>;
                    <volume>138</volume>(
                    <issue>4</issue>):
                    <fpage>1016</fpage>–
                    <lpage>29</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jaci.2016.06.061</pub-id>
                    <pub-id pub-id-type="pmid">27720016</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b39">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bresciani</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Paradis</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Des Roches</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vernhet</surname>
                     <given-names>H</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vachier</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Godard</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Rhinosinusitis in severe asthma</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2001</year>
                    <month>Jan</month>;
                    <volume>107</volume>(
                    <issue>1</issue>):
                    <fpage>73</fpage>–
                    <lpage>80</lpage>. 
                    <pub-id pub-id-type="doi">10.1067/mai.2001.111593</pub-id>
                    <pub-id pub-id-type="pmid">11149994</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
         <ref id="b40">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>ten Brinke</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grootendorst</surname>
                     <given-names>DC</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Schmidt</surname>
                     <given-names>JT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>De Bruïne</surname>
                     <given-names>FT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>van Buchem</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sterk</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Chronic sinusitis in severe asthma is related to sputum eosinophilia</article-title>. 
                    <source>J Allergy Clin Immunol</source>. 
                    <year>2002</year>
                    <month>Apr</month>;
                    <volume>109</volume>(
                    <issue>4</issue>):
                    <fpage>621</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1067/mai.2002.122458</pub-id>
                    <pub-id pub-id-type="pmid">11941310</pub-id>
                    <issn>0091-6749</issn>
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
